Gout Remission Achievable With Pegloticase-Induced Urate-Lowering Therapy | Docwire News Intensive urate lowering with pegloticase achieved gout remission in 43% to 70% of patients after 52 weeks, depending on the definition used.

After 52 weeks, pegloticase achieved gout remission in 43% to 70% of patients, with rates varying by definition used. #gout #nephrology #urate #pegloticase docwirenews.com/post/gout-re...

Case Report: Pegloticase Treatment Beneficial for GFR Recovery | Docwire News A case report suggests treatment with intravenous pegloticase could help eGFR recovery in patients with uncontrolled gout.

Treatment with #pegloticase could stabilize uncontrolled #gout, with benefits in terms of eGFR recovery and reduction in CKD progression. #kidneywk #kidneydisease #nephsky